ABO血型与半乳糖缺陷型IgA1在IgA肾病不良结局中的关联
本研究纳入1313例IgA肾病患者,中位随访44个月,测量血浆Gd-IgA1水平,采用多因素Cox回归和倾向性评分匹配(718例A或B型患者)分析。发现A型血患者不良结局风险显著高于B型(HR=1.82,95%CI 1.23-2.71,P=0.003),但加入Gd-IgA1/sC3后风险不再显著,提示该风险与Gd-IgA1/sC3相关。
要点
- A型血IgA肾病患者不良结局风险显著高于B型(HR=1.82)。
- A型与B型风险差异在调整Gd-IgA1/sC3后不再显著。
- ABO血型或可作为IgA肾病预后参考指标。
核心结论
- A型血IgA肾病患者不良结局风险高于B型,该风险与Gd-IgA1/sC3相关。
研究设计与样本
- 纳入1313例IgA肾病患者,中位随访44个月,测量血浆Gd-IgA1水平。
- 采用多因素Cox回归评估变量与不良结局的关联。
- 用倾向性评分匹配选取718例A或B型患者分析血型与Gd-IgA1/sC3及结局的关系。
主要发现
- 多因素调整后,A型血患者不良结局风险显著高于B型(HR=1.82,95%CI 1.23-2.71;P=0.003)。
- Gd-IgA1水平呈现与血型多因素调整后无事件曲线相似的趋势。
- 模型中加入Gd-IgA1/sC3后,A型与B型间不良结局风险差异不再显著。
临床怎么用
- ABO血型可能为IgA肾病预后评估提供参考。
- Gd-IgA1/sC3或可解释A型血患者的不良结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both ABO blood group antigens and pathogenic immunoglobulin A1 (IgA1) in patients with IgA nephropathy (IgAN) are influenced by modifications of N-acetylgalactosamine and galactose. The purpose of this study was to assess whether ABO blood type is associated with galactose-deficient IgA1 (Gd-IgA1) in the progression of kidney disease in patients with IgAN. METHODS: We enrolled 1313 IgAN patients with a median of 44 months follow-up and measured the plasma Gd-IgA1 levels. Multivariate Cox regression models were used to estimate the association between all variables and adverse outcomes. Using the propensity score matching method, 718 IgAN patients with blood type either A or B were selected, and their data were used to assess the association of blood type and Gd-IgA1/serum complement 3 (sC3) with outcomes. RESULTS: We found that the risk of adverse outcomes was significantly higher in patients with blood type A than in those with type B (hazard ratio = 1.82, 95% confidence interval 1.23-2.71; P = 0.003) after multivariate adjustment. The Gd-IgA1 levels showed trends similar to the multivariate-adjusted event-free curves for the blood types. However, this higher risk of adverse outcomes in type A than in type B patients was no longer significant after the addition of Gd-IgA1/sC3 to the model. CONCLUSIONS: IgAN patients with blood type A had a higher risk of adverse outcomes than those with type B, and this risk was associated with Gd-IgA1/sC3. Thus, the ABO blood type may provide a reference for the prognostic factors for individuals with IgAN.
引用
- Wang M, Lv J, Chen P, et al. Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy. Nephrol Dial Transplant. 2021. PMID: 31603230. doi:10.1093/ndt/gfz171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。